Stiell IG, Clement CM, Aaron SD, et al. Clinical characteristics associated with adverse events in patients with exacerbation of chronic obstructive pulmonary disease: a prospective cohort study. CMAJ. 2014;186(6):E193-204.

Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36(3):959-69.

Pan AM, Stiell IG, Clement CM, et al. Feasibility of a structured 3-minute walk test as a clinical decision tool for patients presenting to the emergency department with acute dyspnoea. Emergency Medicine Journal. 2009;26:278-282.

Stiell IG, Perry JJ, Clement CM, et al. Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department. CMAJ. 2018;190(48):E1406-E1413.

Dr. Ian Stiell

Ottawa COPD Risk Scale

cabg

peri

intu

walk

xray

hemo

urea

<p>Predicts 30-day mortality or serious adverse events (MI, intubation, etc) in ED patients with COPD.</p>

Death or serious adverse events in COPD (ED setting).

The Ottawa COPD Risk Scale predicts risk of death or serious adverse events in ED patients with COPD.

DECAF Score

COPD Assessment Test (CAT)

BODE Index

EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.

Listen to the VACO co-creators break down how to use VACO\, what it does\, and what it doesn’t.

Calc Function